Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
Cambridge based biotech R&D firm with unparalleled track record looking for investors
| Project region | Britain |
|---|---|
| Industry | Healthcare |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Simon Laube
Assistant Manager, International Business Advisory
| Project highlights | To be confirmed |
|---|---|
| Project description |
The company is a Cambridge based biotechnology contract research and drug development company, which operates a mixed business model. The revenue is generated through its service business and the development of drug products. The company has an excellent track record in candidate drug delivery. It has a world-class discovery team, and its unparalleled track record shows that it has delivered one candidate drug on behalf of its customers every year in the past six years. Revenue in 2019 was approximately £ 6 million, of which 83% of sales came from a strong growing industrial customer base, which has now become the core of the business. |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact UsOur Clients
Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.
See what our clients say about us
